Skip to main content

Table 1 Comparison of clinical and laboratory indicators between groups(\(\overline{\mathrm{X}}\) ±S)

From: Correlation between the accumulation of skin glycosylation end products and the development of type 2 diabetic peripheral neuropathy

Indicators Grade 0 (n = 79) Grade 1 (n = 199) Grade 2 (n = 202) Grade 3 (n = 80) F P
AGEs (AU) 74.36 ± 11.97 84.02 ± 13.88 87.72 ± 15.67 93.99 ± 19.83 24.290 .000*
Course (years) 2.96 ± 2.91 7.54 ± 6.48 10.27 ± 7.23 8.36 ± 5.30 4.032 .009*
Age (years) 50.2 ± 12.71 59.31 ± 11.26 62.06 ± 11.89 69.85 ± 10.87 39.423 .000*
Weight (kg) 62.91 ± 12.95 65.22 ± 11.51 63.58 ± 11.10 62.71 ± 10.31 1.420 .236
BMI (kg/m2) 24.31 ± 3.50 24.48 ± 3.34 24.42 ± 3.79 23.70 ± 3.12 1.031 .378
Ca2+(mmol/L) 2.21 ± 0.14 2.21 ± 0.13 2.19 ± 0.15 2.18 ± 0.13 1.293 .276
UA (μmol/L) 316.98 ± 100.82 336.52 ± 100.30 332.97 ± 100.92 355.74 ± 90.62 2.074 .103
TC (mmol/L) 4.62 ± 1.17 4.40 ± 1.16 4.40 ± 1.08 4.39 ± 1.36 .815 .486
LDL (mmol/L) 2.69 ± 0.91 2.57 ± 0.81 2.54 ± 0.78 2.54 ± 0.88 .617 .604
WBC (*109/L) 6.05 ± 1.83 6.10 ± 1.93 6.14 ± 1.89 6.02 ± 2.17 .067 .978
1hPBG (mmol/L) 14.99 ± 4.24 14.27 ± 3.56 15.31 ± 2.72 15.02 ± 4.48 .506 .679
2hPBG (mmol/L) 17.71 ± 5.17 18.07 ± 4.25 17.29 ± 4.83 20.85 ± 6.18 2.453 .064
3hPBG (mmol/L) 15.97 ± 6.60 16.30 ± 4.62 18.52 ± 3.13 19.15 ± 4.95 1.716 .171
INS60’(mIU/L) 47.41 ± 54.60 25.75 ± 17.67 17.95 ± 10.10 13.08 ± 5.48 4.106 .009*
INS120’(mIU/L) 62.25 ± 70.87 28.90 ± 17.50 24.61 ± 14.71 15.93 ± 9.89 4.613 .005*
INS180’(mIU/L) 48.10 ± 54.17 28.66 ± 18.60 25.82 ± 15.55 19.35 ± 9.55 2.291 .085
  1. * The significance level of the mean difference is 0.05